Skip to content

Influencing Factors of Cerebrovascular Disease and Cognition in Hemodialysis Patients

Influencing Factors of Cerebrovascular Disease and Cognition in Hemodialysis Patients: an Observational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04433455
Enrollment
20
Registered
2020-06-16
Start date
2020-06-01
Completion date
2025-05-31
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovascular Disorders, Cognitive Impairment, Hemodialysis

Brief summary

In this observational study, the investigators evaluate the influencing factors of cerebrovascular disease and cognition in hemodialysis patients.

Interventions

None listed

Sponsors

Huashan Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. maintenance hemodialysis patients who are younger than 85 years old and older than 50 years old, regardless of gender 2. dialysis vintage is greater than 3 months;

Exclusion criteria

1. Those with severe infection and anemia (Hb \<60g / L); 2. Those with severe mental illness, metabolic diseases and immune system diseases; 3. Patients with abnormal liver function

Design outcomes

Primary

MeasureTime frameDescription
cerebrovascular disease5 yearsMagnetic resonance images will be used to determine the severity of white matter hyperintensity, using the Scheltens scale. Score 2 or more is abnormal.

Secondary

MeasureTime frameDescription
changes in cognitive function5 yearsThe Mini-Mental State Examination (MMSE) will be used to assess the changes in cognitive function.The MMSE has a maximum score of 30 points. The scores are generally grouped as follows: 25-30 points: normal cognition 21-24 points: mild dementia 10-20 points: moderate dementia 9 points or lower: severe dementiaThe Mini-Mental State Examination (MMSE) will be used to assess the changes in cognitive function.The MMSE has a maximum score of 30 points. The scores are generally grouped as follows: 25-30 points: normal cognition 21-24 points: mild dementia 10-20 points: moderate dementia 9 points or lower: severe dementia

Countries

China

Contacts

Primary ContactJing Chen
chenjing1998@fudan.edu.cn862152889325

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026